Biblio

Author Title [ Type

] Year

Filters: Author is Grønbæk, Kirsten [Clear All Filters]

Journal Article

Wedge E, Hansen JWerner, Dybedal I, Creignou M, Ejerblad E, Lorenz F, Werlenius O, Ungerstedt J, Holm MSkov, Nilsson L, et al. Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: Clinical and molecular genetic prognostic factors in a Nordic population. Transplant Cell Ther. 2021.

Eskelund CWinther, Husby S, Favero F, Klausen TWirenfeldt, Rodriguez-Gonzalez FGerman, Kolstad A, Pedersen LBredo, Räty RKatariina, Geisler CH, Jerkeman M, et al. Clonal hematopoiesis evolves from pre-treatment clones and stabilizes after end of chemotherapy in patients with MCL. Blood. 2020.

Dahl M, Husby S, Eskelund CW, Besenbacher S, Fjelstrup S, Côme C, Ek S, Kolstad A, Räty R, Jerkeman M, et al. Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials. Leukemia. 2021.

Trempenau MLouise, Schuster MBruhn, Pundhir S, Pereira MAraujo, Kalvisa A, Tapia M, Su J, Ge Y, de Boer B, Balhuizen A, et al. The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes. Leukemia. 2023.

Jaberi E, Tresse E, Grønbæk K, Weischenfeldt J, Issazadeh-Navikas S. Identification of unique and shared mitochondrial DNA mutations in neurodegeneration and cancer by single-cell mitochondrial DNA structural variation sequencing (MitoSV-seq). EBioMedicine. 2020;57:102868.

Tentori CA, Zhao LP, Tinterri B, Strange KE, Zoldan K, Dimopoulos K, Feng X, Riva E, Lim B, Simoni Y, et al. Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium. Hemasphere. 2024;8(5):e64.

Wedge E, Sengeløv H, Hansen JWerner, Andersen NSmedegaard, Schjoedt I, Petersen SLykke, Kornblit B, Grønbæk K, Friis LSmidstrup. Improved outcomes after allogenic hematopoietic stem cell transplantation with Fludarabine/Treosulfan for patients with myelodysplastic syndromes. Biol Blood Marrow Transplant. 2020.

Saini SKumar, Holmberg-Thydén S, Bjerregaard A-M, Unnikrishnan A, Dorfmüller S, Platzbecker U, Tirado-Gonzalez I, Bonig H, Fassi DEl, Grønbæk K, et al. Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies. Leukemia. 2022.

Kolstad A, Laurell A, Jerkeman M, Grønbæk K, Elonen E, Räty R, Pedersen LBredo, Loft A, Bogsrud TVelde, Kimby E, et al. Nordic MCL-3 study: BEAM/C conditioning intensified with 90Y-Ibritumomab-Tiuxetan in responding non-CR patients followed by autologous transplant in mantle cell lymphoma. Blood. 2014.

Macintyre E, Döhner K, Grønbæk K, Dreyling M, Huntly B, Almeida A, Gribben J. Precision hematology: Navigating the evolution of diagnostic classifications in the era of globalized medicine. Hemasphere. 2024;8(4):e65.

Trab T, Baech J, Jakobsen LHjort, Husby S, Severinsen MTang, Eloranta S, Gørløv JS, Jørgensen JM, Gudbrandsdottir S, Larsen TStauffer, et al. Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population-based, retrospective cohort study. Lancet Haematol. 2023.